Exchange: OTC·Updated 09:49 AM EDT

PATLF Patrys Limited

$0.06
$0.01
(20.00%)
Today
Mkt Cap$40.49M
Vol20,000.00

About PATLF

Patrys Ltd. engages in the commercialization of the group's proprietary technologies to develop natural human antibody-based therapeutic products for the treatment of cancer and the pursuit of non-dilutive funding sources. Its pipeline includes PAT-DX1 antibody fragment, PAT-DX3 full sized antibody, and PAT-DX1-NP conjugated to nanoparticles. The company was founded by Daniel Devine on December 8, 2006 and is headquartered in South Melbourne, Australia.
50

Sentiment

How do you feel about PATLF?

Advertisement|Remove ads.